New cash shell Spiritus Mundi wants to buy a clinical diagnostics business. No formal discussions have begun.
Diagnostics is an area that has gained plenty of publicity in the past three years. There has been a boost to demand from Covid-19 although the peak was passed a long time ago.
The share price ended the week at 6p (5p/7p). There were no trades recorded. The pro forma net assets are just over 2p a share. More cash could be raised if warrants and options are exercised.
The lack o...
You are unauthorized to view this page.